Home 5 Articles 5 FDA Offers New Guidance on Validating SARS-CoV-2 Tests in “Non-Laboratory” Settings

FDA Offers New Guidance on Validating SARS-CoV-2 Tests in “Non-Laboratory” Settings

by | Aug 20, 2020

SARS-CoV-2 testing in homes, workplaces, airports, schools, sports venues and other non-traditional diagnostic settings is likely to play an increasingly important role in the months ahead. The FDA has indicated that it’s “supportive of testing” in non-laboratory settings, “provided there is data and science to support consumer safety and test accuracy.” And on July 28, […]

SARS-CoV-2 testing in homes, workplaces, airports, schools, sports venues and other non-traditional diagnostic settings is likely to play an increasingly important role in the months ahead. The FDA has indicated that it’s “supportive of testing” in non-laboratory settings, “provided there is data and science to support consumer safety and test accuracy.” And on July 28, […]

This content is Exclusive to Lab Industry Report Subscribers

Subscribe or Log in for Exclusive Access.